SUNNYVALE, Calif., June 10, 2025 /PRNewswire/ — In a major milestone for heart failure treatment, the first commercial patients in the U.S. have been successfully implanted with the FDA-approved WiSE® System—marking the beginning of a new chapter in leadless left ventricular endocardial pacing (LVEP) for the treatment of heart failure.
Breakthrough Non-Invasive Therapy Installed with Support from Li Ka Shing Foundation to Advance Research and Patient Care
EnVVeno Medical (Nasdaq:NVNO) announced three-year outcomes for its heart valve that it aims to submit to the FDA this year.
Revolutionary system combines ultrasonics and ultraviolet energy to destroy airborne pathogens and pollutants beyond traditional purification limits.
GE HealthCare (Nasdaq: GEHC)+
today unveiled Signa Sprint, an ultra-premium wide-bore 1.5% high-performance gradient MRI system.
Launch of Zoom DuoPort enables Continuous Dual Aspiration Technique (CDAT) for safer, faster procedures
MADISON, Wis., May 6, 2025 /PRNewswire/ — The Food and Drug Administration Agency (FDA) has updated the regulatory status of Marie®, Leo Cancer Care’s upright particle therapy solution, to pending. Marie combines Leo Cancer Care’s upright patient positioning system with their upright fan beam CT scanner and can be utilized with any fixed particle beam.
The circuits could help researchers develop new treatments for fragile X syndrome and other diseases caused by mutations of a single gene.
Innovative mesh aims to improve patient outcomes by naturally absorbing into the body post-surgery.
Novocure (Baar, Switzerland) announced today that it has won a CE mark for its Optune Lua wearable device for treating metastatic non-small cell lung cancer.